Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.
In sub-Saharan Africa, women have among the highest fertility rates in the world. Unfortunately, they are also disproportionately at risk for HIV, a leading cause of illness and death among women of reproductive age.
In mammals, including humans, the cells that contract the heart muscle and enable it to beat do not regenerate after injury.
Carnegie Mellon University researchers have developed a new method for delivering chemotherapy nanodrugs that increases the drugs' bioavailability and reduces side-effects.
Xiaocheng Jiang, assistant professor of biomedical engineering in the School of Engineering at Tufts University, has been awarded an early-career award from the Air Force Office of Scientific Research for his work developing graphene-based microfluidics for ultra-high-resolution, dynamic bio-imaging.
A new study conducted at the Northwestern University, published today in the Journal of the American Chemical Society, captured a video of organic nanoparticles colliding and fusing together, a breakthrough in nanotechnology.
Ahead of World COPD Day on November 15, Royal Philips, a leader in health technology, today announced the launch of a global movement to raise awareness for chronic obstructive pulmonary disease (COPD).
Millions of Americans suffer from neurodegenerative diseases such as Alzheimer's and Parkinson's. Researchers have identified promising new treatments, such as cerebrolysin, but current clinical approaches are ineffective because critical concentrations of the drug dissipate within the body before reaching the blood-brain barrier and central nervous system.
Manganese dioxide could make the preparation of micromotors increasingly cost-effective, opening up new avenues for their use, according to a new study from the University of Eastern Finland.
A surprise finding suggests that an injection of nanoparticles may be able to help fight the immune system when it goes haywire, researchers at the University of Michigan have shown. The nanoparticles divert immune cells that cause inflammation away from an injury site.
Researchers investigating ways to deliver high doses of cancer-killing drugs inside tumors have shown they can use a laser and light-activated gold nanoparticles to remotely trigger the release of approved cancer drugs inside cancer cells in laboratory cultures.
A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.
Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.
Pneuma Respiratory has developed the first fully digital, soft mist inhaler. Early clinical studies have shown that the platform can effectively deliver a number of different types of medicines to the lungs.
University of California San Diego researchers have developed the first 3D spatial visualization tool for mapping "'omics" data onto whole organs.
Glioblastoma is the most aggressive cancer that originates in the brain. Current therapies can slow the disease, but more often than not can't cure it.
Fluence Analytics, a manufacturer of realtime, industrial and laboratory monitoring systems, today announced the launch of ARGEN, a patented protein and polymer stability monitoring product. By utilizing continuous light scattering measurements, ARGEN yields a unique information stream which reduces discovery and formulation and development times.
Stand Up To Cancer has awarded a $2.5 million SU2C CatalystR grant to the Translational Genomics Research Institute to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers.
DNA evolved to store genetic information, but in principle this special, chain-like molecule can also be adapted to make new materials. Chemists at The Scripps Research Institute have now published an important demonstration of this repurposing of DNA to create new substances with possible medical applications.
The Pittcon Program Committee is pleased to announce this year’s recipients of 13 prestigious awards honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each award will be presented in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory science, which will be held February 26-March 1, Orange County Convention Center, Orlando, Florida.
RCSI is leading an international team of scientists on a major research study that aims to train the next generation of brain cancer researchers.